These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31288639)

  • 1. Identification of the PCA29 gene signature as a predictor in prostate cancer.
    Lee JY; Lin SY; Lin CY; Chuang YH; Huang SH; Tseng YY; Wang HJ; Yang JM
    J Bioinform Comput Biol; 2019 Jun; 17(3):1940006. PubMed ID: 31288639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental Phenol and Paraben Exposure Risks and Their Potential Influence on the Gene Expression Involved in the Prognosis of Prostate Cancer.
    Alwadi D; Felty Q; Roy D; Yoo C; Deoraj A
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis.
    Ma Z; Wang J; Ding L; Chen Y
    Medicine (Baltimore); 2020 Jul; 99(28):e21158. PubMed ID: 32664150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine Samples.
    Guo J; Yang J; Zhang X; Feng X; Zhang H; Chen L; Johnson H; Persson JL; Xiao K
    Anticancer Res; 2018 Mar; 38(3):1471-1477. PubMed ID: 29491074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA.
    Chen Z; Hu H
    Curr Probl Cancer; 2019 Dec; 43(6):100503. PubMed ID: 31563279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.
    Lyu F; Li Y; Yan Z; He Q; Cheng L; Zhang P; Liu B; Liu C; Song Y; Xing Y
    J Transl Med; 2022 May; 20(1):202. PubMed ID: 35538543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
    Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
    Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
    Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
    J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
    Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
    Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
    Zhang X; Wang Y; Ning Y
    Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
    Zhang W; Shu P; Wang S; Song J; Liu K; Wang C; Ran L
    Gene; 2018 Oct; 675():136-143. PubMed ID: 29966681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of miR-375 in prostate cancer: A study based on GEO, TCGA data and bioinformatics analysis.
    He S; Shi J; Mao J; Luo X; Liu W; Liu R; Yang F
    Pathol Res Pract; 2019 Jun; 215(6):152375. PubMed ID: 30879885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebellar degeneration-related autoantigen 1 (CDR1) gene expression in prostate cancer cell lines.
    Salemi M; Fraggetta F; Galia A; Pepe P; Cimino L; Condorelli RA; Calogero AE
    Int J Biol Markers; 2014 Sep; 29(3):e288-90. PubMed ID: 24366849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
    Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
    BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
    Foj L; Filella X
    Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
    Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
    Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Stage Biomarkers Screening of Prostate Cancer Based on Weighted Gene Coexpression Network Analysis.
    Meng L; Li Y; Ren J; Shi T; Men J; Chang C
    DNA Cell Biol; 2019 May; 38(5):468-475. PubMed ID: 30835547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of the diagnostic value and molecular mechanism of miR‑1 in prostate cancer: A study based on meta‑analyses and bioinformatics.
    Xie ZC; Huang JC; Zhang LJ; Gan BL; Wen DY; Chen G; Li SH; Yan HB
    Mol Med Rep; 2018 Dec; 18(6):5630-5646. PubMed ID: 30365107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21.
    Liang Z; Mou Q; Pan Z; Zhang Q; Gao G; Cao Y; Gao Z; Pan Z; Feng W
    Med Oncol; 2019 May; 36(6):56. PubMed ID: 31089825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.